John Yeoman

John Yeoman is currently working as a Senior Principal Scientist in Medicinal Chemistry at Recludix Pharma. Prior to this role, John held positions at X-Chem, Inc. and Amgen, where John focused on designing and synthesizing novel bioactive compounds for various therapeutic discovery programs. John completed their Ph.D. in Organic Chemistry at Caltech after earning their Bachelor of Arts in Chemistry from Grinnell College.